BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8632904)

  • 21. Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2.
    Somasundaram K; Jayaraman G; Williams T; Moran E; Frisch S; Thimmapaya B
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3088-93. PubMed ID: 8610173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional repression by human adenovirus E1A N terminus/conserved domain 1 polypeptides in vivo and in vitro in the absence of protein synthesis.
    Song CZ; Tierney CJ; Loewenstein PM; Pusztai R; Symington JS; Tang QQ; Toth K; Nishikawa A; Bayley ST; Green M
    J Biol Chem; 1995 Oct; 270(40):23263-7. PubMed ID: 7559479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE; Khalili K; Amini S
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the human proliferating cell nuclear antigen promoter by the adenovirus E1A-associated protein p107.
    Lee BH; Liu M; Mathews MB
    J Virol; 1998 Feb; 72(2):1138-45. PubMed ID: 9445010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple pathways for activation of E2A expression in human KB cells by the 243R E1A protein of adenovirus type 5.
    Mymryk JS; Bayley ST
    Virus Res; 1994 Jul; 33(1):89-97. PubMed ID: 7941702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repression of RNA polymerase III transcription by adenovirus E1A.
    Sollerbrant K; Akusjärvi G; Svensson C
    J Virol; 1993 Jul; 67(7):4195-204. PubMed ID: 8510221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.
    Kundu M; Srinivasan A; Pomerantz RJ; Khalili K
    J Virol; 1995 Nov; 69(11):6940-6. PubMed ID: 7474112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery.
    Sakaguchi M; Zenzie-Gregory B; Groopman JE; Smale ST; Kim SY
    J Virol; 1991 Oct; 65(10):5448-56. PubMed ID: 1895393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional coactivator cAMP response element binding protein mediates induction of the human proliferating cell nuclear antigen promoter by the adenovirus E1A oncoprotein.
    Lee BH; Mathews MB
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4481-6. PubMed ID: 9114015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The transcription-repression domain of the adenovirus E1A oncoprotein targets p300 at the promoter.
    Green M; Panesar NK; Loewenstein PM
    Oncogene; 2008 Jul; 27(32):4446-55. PubMed ID: 18408753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
    Subler MA; Martin DW; Deb S
    J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.
    Laspia MF; Rice AP; Mathews MB
    Genes Dev; 1990 Dec; 4(12B):2397-408. PubMed ID: 2149119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ad E1A 243R oncoprotein promotes association of proto-oncogene product MYC with the NuA4/Tip60 complex via the E1A N-terminal repression domain.
    Zhao LJ; Loewenstein PM; Green M
    Virology; 2016 Dec; 499():178-184. PubMed ID: 27664947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional repression of interleukin-6 gene by adenoviral E1A proteins.
    Janaswami PM; Kalvakolanu DV; Zhang Y; Sen GC
    J Biol Chem; 1992 Dec; 267(34):24886-91. PubMed ID: 1332971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter.
    Labrie C; Lee BH; Mathews MB
    Nucleic Acids Res; 1995 Sep; 23(18):3732-41. PubMed ID: 7479004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression.
    Tsuji Y; Akebi N; Lam TK; Nakabeppu Y; Torti SV; Torti FM
    Mol Cell Biol; 1995 Sep; 15(9):5152-64. PubMed ID: 7651432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
    Berkhout B; Jeang KT
    J Virol; 1992 Jan; 66(1):139-49. PubMed ID: 1727476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.